• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Ciprofloxacin Teva
    / Teva


    Active Ingredient
    Ciprofloxacin (HCl) 250, 500, 750 mg

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Tablets

    10 X 250 mg

    partial basket chart 52457 3724

    Tablets

    10 X 500 mg

    partial basket chart 52666 3723

    Tablets

    10 X 750 mg

    partial basket chart 3753

    Related information


    Dosage

    See prescribing information for full details.


    Indications

    Broad spectrum antibiotic for infections caused by ciprofloxacin-sensitive pathogens: invasive infections of the external ear. Treatment of acute pulmonary exacerbation of cystic fibrosis associated with Pseudomonas aeruginosa in pediatric patients aged 5-17 years.

     


    Contra-Indications

    Please refer to the manufacturer for further information.


    Special Precautions

    Please refer to the manufacturer for further information.


    Side Effects

    Please refer to the manufacturer for further information.


    Drug interactions

    Please refer to the manufacturer for further information.


    Manufacturer
    Teva Pharmaceutical Industries Ltd, Israel
    CLOSE